Getting therapeutic drugs past the blood-brain barrier has long been a major challenge in treating brain diseases. Now, researchers have explored how cholesterol-modified heteroduplex oligonucleotides ...

CROs can contribute to site collaboration by also identifying and supporting non-academic institutions capable of conducting ...